TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, Mori H, Mann D, Tsuchiya K, Yoshida M, Hashizume Y, Oda T

Biochem Biophys Res Commun, (3):602-611 2006

MED: 17084815

Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy.

Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, Niizato K, Tsuchiya K, Kobayashi Z, Ikeda K, Yoshida M, Onaya M, Fujishiro H, Akiyama H

Neuropathology, (2):170-181 2010

MED: 20102522

Impairment of the ubiquitin-proteasome system by protein aggregation.

Bence NF, Sampat RM, Kopito RR

Science, (5521):1552-1555 2001

MED: 11375494

Inclusions in frontotemporal lobar degeneration with TDP-43 proteinopathy (FTLD-TDP) and amyotrophic lateral sclerosis (ALS), but not FTLD with FUS proteinopathy (FTLD-FUS), have properties of amyloid.

Bigio EH, Wu JY, Deng HX, Bit-Ivan EN, Mao Q, Ganti R, Peterson M, Siddique N, Geula C, Siddique T, Mesulam M

Acta Neuropathol, (3):463-465 2013

MED: 23378033

Neuropathological stageing of Alzheimer-related changes.

Braak H, Braak E

Acta Neuropathol, (4):239-259 1991

MED: 1759558

Staging of brain pathology related to sporadic Parkinson's disease.

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E

Neurobiol Aging, (2):197-211 2003

MED: 12498954

Title not supplied

Brooks

J. Neurol. Sci., (Suppl) 1994

Cellular model of TAR DNA binding protein 43 (TDP-43) aggregation based on its C-terminal Q/N rich region

Budini

J. Biol. Chem. 2012

The molecular links between TDP-43 dysfunction and neurodegeneration.

Buratti E, Baralle FE

Adv Genet, 1-34 2009

MED: 19737636

Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE

EMBO J, (7):1774-1784 2001

MED: 11285240